NCT00054314View on ClinicalTrials.gov

BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2002

Primary Completion Date

April 30, 2003

Conditions
Lung Cancer
Interventions
DRUG

ortataxel

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00054314 - BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter